Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is P  [Clear All Filters]
Xu, R. (2019). P4HA1 is a new regulator of the HIF-1 pathway in breast cancer.Cell Stress3, 27-28.
Koifman, G., Aloni-Grinstein, R., and Rotter, V. (2019). p53 balances between tissue hierarchy and anarchy.J Mol Cell Biol.
Santoro, A., Vlachou, T., Luzi, L., Melloni, G., Mazzarella, L., D'Elia, E., Aobuli, X., Pasi, C.Elisabetta, Reavie, L., Bonetti, P., et al. (2019). p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value.Cell Rep26, 624-638.e8.
J Beeler, S., Marshall, C.B., Gonzalez-Ericsson, P.I., Shaver, T.M., Guasch, G.L.Santos, Lea, S.T., Johnson, K.N., Jin, H., Venters, B.J., Sanders, M.E., et al. (2019). p73 regulates epidermal wound healing and induced keratinocyte programming.Plos One14, e0218458.
Cesaro, S., Mauro, M., Sattin, G., Sartori, M.Teresa, Saggiorato, G., Paratella, A., Tridello, G., and Bisogno, G. (2019). PAI-1 and protein C as early markers of veno-occlusive disease in patients treated for Wilms tumor.Pediatr Blood Cancere27695.
de Faria, C.Arruda, Zanette, D.Luciola, Silva, W.Araújo, and Ribeiro-Paes, J.Tadeu (2019). PAI-1 inhibition by simvastatin as a positive adjuvant in cell therapy.Mol Biol Rep.
Santiago-Gómez, A., Kedward, T., Simões, B.M., Dragoni, I., NicAmhlaoibh, R., Trivier, E., Sabin, V., Gee, J.M., Sims, A.H., Howell, S.J., et al. (2019). PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer.Cancer Lett.
Chefetz, I., Grimley, E., Yang, K., Hong, L., Vinogradova, E.V., Suciu, R., Kovalenko, I., Karnak, D., Morgan, C.A., Chtcherbinine, M., et al. (2019). A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells.Cell Rep26, 3061-3075.e6.
Chang, W.Hoong, and Lai, A.G. (2019). Pan-cancer genomic amplifications underlie a WNT hyperactivation phenotype associated with stem cell-like features leading to poor prognosis.Transl Res.
Gueudry, J., Majo, F., Delcampe, A., and Muraine, M. (2019). [Panorama of limbal alterations].J Fr Ophtalmol.
El-Serafi, A.T., Sandeep, D., Abdallah, S., Lozansson, Y., Hamad, M., and Khan, A.A. (2019). Paradoxical effects of the epigenetic modifiers 5-aza-deoxycytidine and suberoylanilide hydroxamic acid on adipogenesis.Differentiation106, 1-8.
Huang, M., Cai, Q., Xu, Y., Guo, M., Zhu, C., Li, Y., Wu, K., Zhou, Z., and Yang, H. (2019). Paraquat affects the differentiation of neural stem cells and impairs the function of vascular endothelial cells: a study of molecular mechanism.Environ Toxicol.
Price, R.J., Fisher, D.G., Suk, J.Soo, Hanes, J., Ko, H.Seok, and Kordower, J.H. (2019). Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?.Mov Disord.
Raza, C., Anjum, R., and Shakeel, N.Ul Ain (2019). Parkinson's disease: Mechanisms, translational models and management strategies.Life Sci.
Lopes, H.B., Freitas, G.P., Elias, C.N., Tye, C., Stein, J.L., Stein, G.S., Lian, J.B., Rosa, A.L., and Beloti, M.M. (2019). Participation of Integrin β3 in Osteoblast Differentiation Induced by Titanium with Nano or Microtopography.J Biomed Mater Res A.
Wu, P., Pu, L., Deng, B., Li, Y., Chen, Z., and Liu, W. (2019). PASS: A Proteomics Alternative Splicing Screening pipeline.Proteomicse1900041.
Morita, Y., Okura, H., and Matsuyama, A. (2019). Patent Application Trends of Induced Pluripotent Stem Cell Technologies in the United States, Japanese, and European Applications.Biores Open Access8, 45-58.
Wang, Z., Wang, L., Liu, W., Hu, D., Gao, Y., Ge, Q., Liu, X., Li, L., Wang, Y., Wang, S., et al. (2019). Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.Stem Cell Res38, 101483.
Chavali, N.V., Kryshtal, D.O., Parikh, S.S., Wang, L., Glazer, A.M., Blackwell, D.J., Kroncke, B.M., Shoemaker, M.Benjamin, and Knollmann, B.C. (2019). The patient-independent human iPSC model - a new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.Heart Rhythm.
Ahmedzai, S.H., Snowden, J.A., Ashcroft, A.John, Cairns, D.Allan, Williams, C., Hockaday, A., Cavenagh, J.D., Ademokun, D., Tholouli, E., Allotey, D., et al. (2019). Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.J Clin OncolJCO1801006.
von Tresckow, B., Fanale, M., Ardeshna, K.M., Chen, R., Meissner, J., Morschhauser, F., Moskowitz, C., Zinzani, P.Luigi, Giezek, H., Balakumaran, A., et al. (2019). Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma.Leuk Lymphoma1-7.
Mobasseri, S.Atefeh, Zijl, S., Salameti, V., Walko, G., Stannard, A., Garcia-Manyes, S., and Watt, F.M. (2019). Patterning of human epidermal stem cells on undulating elastomer substrates reflects differences in cell stiffness.Acta Biomater.
Paudel, N., Schulze, D., Gentzler, R.D., Evens, A.M., Helenowski, I., Dillehay, G., Frankfurt, O., Mehta, J., Donnelly, E.D., Gordon, L.I., et al. (2019). Patterns of Failure and Survival Outcomes After Total Lymphoid Irradiation and High-Dose Chemotherapy With Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.Int J Radiat Oncol Biol Phys.
Dimitrioglou, N., Kanelli, M., Papageorgiou, E., Karatzas, T., and Hatziavramidis, D. (2019). Paving the way for successful islet encapsulation.Drug Discov Today.
Huang, X., Wei, C., Li, F., Jia, L., Zeng, P., Li, J., Tan, J., Sun, T., Jiang, S., Wang, J., et al. (2019). PCGF6 regulates stem cell pluripotency as a transcription activator via super-enhancer dependent chromatin interactions.Protein Cell.